Search - tctmd.com

Displaying 581 - 595 of 595

Sort: Relevancy | Date

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Daily News

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

Leah Lawrence

August 30, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

News Conference News

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Jason Kahn

May 18, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Daily News

Higher BMI Linked to Lower Mortality, More Metabolic Disorders After PCI

L.A. McKeown

April 12, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

CME

Advertisement

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Post-Acute MI Survival Improving for Elderly Patients in France

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Higher BMI Linked to Lower Mortality, More Metabolic Disorders After PCI

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content